We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mark Drazner

Mark H Drazner MD, MSc

Clinical Chief of Cardiology, Director of the VAD/Heart Transplant Program, James M. Wooten Chair in Cardiology, University of Texas Southwestern Medical Center, Dallas, TX

Mark H. Drazner, MD, MSc is the Clinical Chief of Cardiology, Director of the VAD/Heart Transplant Program, and holds the James M. Wooten Chair in Cardiology at University of Texas Southwestern Medical Center. His research interests include the utility of the clinical examination in heart failure and the progression from cardiac hypertrophy to failure. He has served on several writing committees for the American Heart Association (AHA)/American College of Cardiology (ACC) Guidelines for the Management of Heart Failure, currently serves on the Heart Failure Society of America (HFSA) Board of Directors, and as Associate Editor for Circulation. He was the inaugural recipient of the L. David Hillis Award for Excellence in Teaching from the UT Southwestern Cardiology Fellowship program. In 2018, he received the Laennec Master Clinician Award from the AHA.

Disclosures

Dr. Drazner reports no relevant disclosures.